Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
International Journal of Laboratory Hematology
|
May 10, 2018
Direct oral anticoagulants: When to consider laboratory testing?
H Ten Cate, R H Olie, A J Ten Cate-Hoek, et al.
Annals of Neurology
|
March 1, 1984
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease
H Ten Cate, C P Henny, H R Büller, et al.
British Journal of Haematology
|
June 1, 1996
Clearance of human factor XIa-inhibitor complexes in rats
W A Wuillemin, W K Bleeker, J Agterberg, et al.
Thrombosis and Haemostasis
|
February 3, 1987
Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate
H ten Cate, C P Henny, J W ten Cate, et al.
Handbook of Experimental Pharmacology
|
August 11, 2020
Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis
R H Olie, P E J van der Meijden, H M H Spronk, et al.
European Urology
|
January 1, 1984
Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma
C P Henny, H ten Cate, N F Dabhoiwala, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa
W A Wuillemin, E Eldering, F Citarella, et al.
Blood
|
July 1, 1989
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
K A Bauer, H ten Cate, S Barzegar, et al.
Thrombosis and Haemostasis
|
October 1, 1996
Inactivation of factor Xia in vivo: studies in chimpanzees and in humans
W A Wuillemin, C E Hack, W K Bleeker, et al.
Thrombosis and Haemostasis
|
June 1, 2002
Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistance
A J ten Cate, Y T van de Hoek, P H Reitsma, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
International Journal of Laboratory Hematology
|
May 10, 2018
Direct oral anticoagulants: When to consider laboratory testing?
H Ten Cate, R H Olie, A J Ten Cate-Hoek, et al.
Annals of Neurology
|
March 1, 1984
Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease
H Ten Cate, C P Henny, H R Büller, et al.
British Journal of Haematology
|
June 1, 1996
Clearance of human factor XIa-inhibitor complexes in rats
W A Wuillemin, W K Bleeker, J Agterberg, et al.
Thrombosis and Haemostasis
|
February 3, 1987
Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate
H ten Cate, C P Henny, J W ten Cate, et al.
Handbook of Experimental Pharmacology
|
August 11, 2020
Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis
R H Olie, P E J van der Meijden, H M H Spronk, et al.
European Urology
|
January 1, 1984
Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma
C P Henny, H ten Cate, N F Dabhoiwala, et al.
The Journal of Biological Chemistry
|
May 31, 1996
Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa
W A Wuillemin, E Eldering, F Citarella, et al.
Blood
|
July 1, 1989
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
K A Bauer, H ten Cate, S Barzegar, et al.
Thrombosis and Haemostasis
|
October 1, 1996
Inactivation of factor Xia in vivo: studies in chimpanzees and in humans
W A Wuillemin, C E Hack, W K Bleeker, et al.
Thrombosis and Haemostasis
|
June 1, 2002
Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistance
A J ten Cate, Y T van de Hoek, P H Reitsma, et al.
Page
of 19